Introduction
HIV-1 may compromise balance or gait at multiple levels of the nervous system [1, 2] with the potential for an additive effect and a pronounced mobility impairment. The factors which can independently or cumulatively contribute to balance and gait problems in HIV/AIDS patients include peripheral neuropathies [3] [4] [5] [6] , PML [7] , muscle weakness [8] , myalgia and fatigue [9] , and cerebellar [10, 11] and basal ganglia lesions [1, 12] . Clinical evidence of balance or gait disturbance is reported in more than 57% of symptomatic HIV-1 seropositive patients and 25% of their asymptomatic peers [13, 14] . Quantitative assessments of posture and stance stabilization have confirmed the clinical data. For example, both Arendt and colleagues [13] and Beckley and colleagues [15] examined balance and postural reflexes in a seronegative control group and in HIV-1 seropositive patients while they stood on a force-sensitive platform. Static ataxia, estimated by sway area, was significantly exaggerated in the HIV-1 seropositive group. Furthermore, the amplitude of the stance-stabilizing reflex following a sudden perturbation of the supporting platform was significantly exaggerated in that group.
Balance and gait problems in HIV/AIDS patients may be influenced by other factors. Although several studies have shown improved motor function following the introduction of antiretroviral treatment [16, 17] , adverse effects have also been observed. Co-morbid psychiatric disorders, including substance abuse/dependence and depression, may enhance the degree of disability [18] [19] [20] [21] [22] [23] [24] .
The goal of the present study was to assess sensorimotor function in a large sample of HIV/AIDS patients and an HIV-1 seronegative control group. Importantly, both patient and control groups included a sufficient number of members to permit a powerful analysis of the effects of moderating and amplifying variables. Another unique feature of the study was its focus on medically-stable outpatients, for whom frailty originating from acute illness and opportunistic disease was less likely to be a confound. The list of dependent measures included quantitative posturographic indices recorded during the Sensory Organization Test, indices of gait speed and efficiency, tactile sensitivity, and proximal strength.
Methods

Subject Recruitment and Screening
Ninety HIV-1 seropositive subjects were recruited via advertisements posted within outpatient Infectious Disease Clinics in the greater Hartford, CT region. Interested individuals were invited to telephone a member of the research staff for eligibility screening. The telephone interview included questions about demographic characteristics, general medical status, substance use, and psychiatric symptoms. Individuals who passed the initial telephone screen were invited to visit the Health Center on a subsequent day, on which an IRB-approved consent form and a medical records release were signed. Additional eligibility screening, laboratory evaluations, and sensorimotor testing were performed on that day.
The most common method for recruiting the 78 members of the HIV-1 seronegative group was wordof-mouth advertising provided by the seropositive participants. HIV-1 seronegative volunteers were invited to telephone the research assistant for initial screening and were brought to the Health Center for further screening. They were subject to the same protocol as the outpatients.
After completing the informed consent and medical release documents, all subjects were asked to provide a blood sample for laboratory confirmation of HIV serostatus. The laboratory work-up also included CBC with differential, HIV RNA viral load, CD4 lymphocyte count and percent, VDRL, HBV screen, HCV, toxoplasmosis and cytomegalovirus antibody titers, renal and liver function, serum protein, albumin, and G-6-PD. Toxicological analyses for cocaine, opiates, amphetamine, and marijuana were performed on urine samples (Ontrak TM , Varian Inc., Palo Alto, CA) and a breathalyzer was used to detect recent alcohol use. In addition, an Optec 2000 Vision Tester TM was used to confirm normal visual acuity (with correction).
A structured psychiatric interview, the Computerized Diagnostic Interview Schedule for DSM-IV [25, 26] , was then administered for the purpose of detecting DSM-IV Axis I and II disorders. Subjects also completed questionnaires or brief interviews assessing medical history, medication use, family history, demographics, psychiatric symptoms, alcohol and drug use, and cognitive status. The assessments included the Addiction Severity Index [27] , Michigan Alcoholism Screening Test [28] , Drug Abuse Screening Test [29] , and Beck Depression Inventory Version II [30] . In addition, the Kaufman Brief Intelligence Test [31] was administered to derive an estimate of IQ.
Exclusion criteria included pregnancy, seizures, mental retardation, neurosurgery, and a history of head injury with loss of consciousness for greater than 10 minutes. In addition, subjects were required to have no acute illness, and no major neurological (i.e., epilepsy, seizure disorder), psychiatric (i.e., DSM-IV defined schizophrenia or bipolar disorder) or medical disorders unrelated to HIV/AIDS (i.e., chronic obstructive pulmonary disease, Type 1 diabetes, cirrhosis, hepatic encephalopathy, ocular disorders, etc.). Subjects were not required to abstain from drugs of abuse prior to testing, although urine and breath samples were assayed, and data regarding quantity, frequency and recency of use were collected.
Group Assignment
Subjects were assigned to groups based upon the results of the HIV screen and a review of medication usage. The 90 HIV-1 seropositive patients were subdivided into groups who reported: (1) no current use of antiretroviral medication or a failure to adhere to an antiretroviral medication regimen for more than 90% of days during the past month (n ¼ 28); (2) current use and >90% adherence to a regimen of only nucleoside analogues (n ¼ 25); or (3) current use and >90% adherence to HAART (n ¼ 37).
Procedures
Sensory Organization Test
Balance was recorded with a system consisting of a force-sensitive platform, A/D converter, and computer (Equi-Test System, NeuroCom International, Inc.). The A/D converter digitized each voltage output from the platform at a rate of 100 Hz. Balance was measured while the subject stood erect in stocking feet.
A computerized Sensory Organization test was employed, consisting of three conditions. All of the conditions provided inaccurate somatosensory information in which the support platform was programmed to track changes in the subject's center of gravity (i.e., sway-referenced). The differences across conditions related to the amount of visual information available to the subject regarding posture and sway. In the first condition, visual input was normal and, in the second condition, eyes were closed, i.e., visual input was absent. In the third condition, eyes were open but the visual horizon was sway-referenced, i.e., visual input was inaccurate. Three 20-second trials were completed for each condition. The dependent variables for each condition were the Equilibrium Quotient (EQ), number of falls, and time before a fall. The sum of falls across individual conditions was also examined.
The Equilibrium Quotient is a continuous measure of postural stability which can range between 0 and 100. Perfect postural stability, without sway, is defined by a score of 100. Data were retained if the subject completed at least one of the three 20-sec trials in each SOT condition without experiencing a fall. If the subject fell during a trial, the EQ data for that trial were deleted and the EQ score was the average of the remaining trials.
Time before a fall was expressed in seconds for each SOT condition. In the event that no fall occurred, subjects received a score of 20 seconds, indicating that postural stability was maintained throughout the condition.
Functional Base of Support (FBOS)
While standing on a fixed support surface and wearing a shoulder harness, subjects were instructed to lean as far forward as possible without losing balance. In a second condition, subjects were instructed to lean as far backward as possible without losing balance. Each condition was composed of two trials. An index of lean performance was calculated by adding the larger of the two forward lean values to the larger of the two backward lean values. This value represents the range over which the base of support remains functional. The lean performance index was then divided by foot length, and this ratio served as an estimate of the functional base of support.
Single Leg Stance Time
Subjects were instructed to stand for as long as possible on one leg with the arms crossed over the chest. Four trials were conducted, alternating between preferred and nonpreferred legs. Rest breaks were permitted between trials. The dependent variable was the length of time that the single leg stance was maintained (maximum 30 seconds). The single best score was retained for preferred and nonpreferred leg trials.
Gait Speed and Cadence
To produce a measure of ''normal'' gait speed, subjects were asked to walk 8 meters at their usual pace. In a second condition, estimating ''fast'' gait speed, subjects were asked to walk 8 meters as quickly as possible without running. The times required to complete these conditions were recorded. Cadence, defined as the time to complete 5 footfalls using the leading foot, was derived for both ''normal'' and ''fast'' pace conditions. Two trials were conducted and averaged.
3608 Turn Subjects were instructed to complete a 3608 turn as quickly as possible. Both a right turn and a reversal were executed and an average of the two trials was computed.
Repeated Chair Rises
Subjects were instructed to alternate rapidly between standing and sitting 5 times without pauses and with arms crossed. The time required to complete the task was recorded.
Vibrotactile Threshold Subjects were instructed to rest the great toe of the right foot upon a buzzer-like device (Bio-Thesiometer; Biomedical Instrument company, Newbury, Ohio) which delivered a 120 Hz vibration of programmable amplitude. The sensory threshold for detecting a change in the amplitude of vibration was recorded. Thresholds were measured during an ascending and descending series and averaged.
Results
Background Characteristics
Group differences in background characterics were evaluated using univariate ANOVA for continuous measures and Pearson's x 2 Test for categorical measures. A summary of the background characteristics of the four subject groups is shown in Table 1 .
The four subject group were similar in age, educational level, and intelligence. In general, the subjects were middle-aged, had completed 11-12 years of education, and possessed normal or below-normal intelligence. Most were female and members of a racial or ethnic minority.
A substantial percentage of the sample reported a history of substance abuse. Rates of substance dependence varied significantly across the groups. HIV-seropositive subjects who were not receiving or complying with antiretroviral treatment reported the highest rates of substance dependence and were more likely to provide a urine toxocology test positive for cocaine or opiates. The members of this group also reported more depression symptoms than the HIV-seronegative control group.
Analyses of HIV disease severity revealed the expected pattern. Viral load was greatest among HIV-seropositive not receiving antiretroviral treatment and lowest among HIV-seropositive patients receiving combined antiretroviral therapy (HAART). CD4 cell count was lower in the three HIV-1 seropositive groups than in the seronegative control group. However, CD4 cell count did not vary significantly as a function of the presence or type of antiretroviral treatment.
Sensorimotor Tests
Independent analyses of inter-related dependent measures can confer an increased of Type I error. In an attempt to control the experiment-wise error rate, all variables were first tested simultaneously within a multivariate analysis of variance. Univariate tests of the effect of Group on individual variables were performed only if the MAN-OVA yielded a significant result.
Within the MANOVA and subsequent ANOVAs, several covariates were specified. They included: the number of alcohol and drug use problems from the MAST and DAST-10, respectively; the number of depression symptoms from the BDI-II; and body mass index. Tukey post hoc tests were used to determine the significance of pairwise differences.
The MANOVA revealed significant effects of several of the covariates. Body mass index [MANOVA F (19, 142) Tukey post hoc tests were employed to evaluate the source of the group differences (see Fig. 1 ). The tests revealed that the three HIV-1 seropositive groups differed significantly from the seronegative group on Equilibrium Quotient and the functional base of support. Differences related to the presence or form of antiretroviral treatment were not significant.
Post hoc analyses of vibrotactile threshold data revealed a more complex pattern of findings. Sensory thresholds were higher in the untreated (HIVþ,TXÀ) and HAART (HIVþ, HAART) groups in comparison to the HIVÀand HIVþ, NRTI groups. There were no significant differences among the other groups.
Secondary Analyses
Because the four subject groups differed in the prevalence of substance dependence and Major Depressive Disorder, a confound may exist which precludes the identification of the proximate cause of the sensorimotor differences. For the purpose of simplifying the interpretation of the results, a series of secondary analyses were performed. For all of these analyses, the HIV-1 seronegative control group was dropped.
In the first series of analyses, the 90 HIV-1 seropositive patients were regrouped based upon DSM-IV diagnoses of Alcohol, Cocaine, or Opiate Dependence, or Major Depressive Disorder-Recurrent. Separate analyses were performed for each of the diagnoses. For the substance dependence diagnoses, subjects could be assigned to one of three levels: never dependent, formerly dependent (i.e., prior to the past year), currently dependent (i.e., during the past year). The dependent measures were the three measures shown sensitive to the effects of HIV and antiretroviral treatment in the major analysis. Table 2 summarizes the results. ANOVAs revealed no significant effects (i.e., all p's > 0.05) of substance dependence or Major Depressive Disorder on the Equilibrium Quotient score, vibrotactile threshold, or functional base of support.
Another analysis series examined the association between markers of HIV disease severity and the three measures significantly affected by HIV-1 in the major analysis. Spearman rank-order correlations were computed between viral load, CD4 cell count, and the selected measures. Two of the correlations were significant. CD4 cell count was positively related to the functional base of support (rho ¼ 0.38, p < 0.05). Viral load was positively correlated with vibrotactile threshold (rho ¼ 0.32, p < 0.05).
Discussion
The present study evaluated balance, gait, strength, and sensory function in 90 HIV-1 infected outpatients and in a control group of 78 uninfected volunteers. The focus on medically-stable outpatients is noteworthy. If the present study had instead included inpatients, or outpatients experiencing an acute phase of illness, then questions would arise as to whether the group differences are merely reflecting frailty and an effect that might be found in any disease. The preservation of group differences when body mass index was entered as a covariate further discounts frailty as the proximate cause. Another finding which discounts frailty is the absence of significant group differences on measures of proximal strength (viz., 3608 turn time and time-to-complete 5 chair rises).
The present study is relatively unique in ensuring that the HIV-1 seropositive and seronegative groups were similar in background characteristics. As noted previously, many of the subjects in the seronegative control group were recruited via word-of-mouth advertising provided by the outpatients. An advantage of this recruitment method, versus other methods, is the ability to sample the control group from a population demographically similar to that of the patients. Importantly, it is also thereby possible to recruit a large number of seronegative controls who resemble the outpatients in psychiatric and substance use characteristics. The results shown in Table 1 demonstrate that the recruitment method was successful in maintaining equivalence across groups with respect to the lifetime number of alcohol and drug use problems reported on the MAST and DAST-10, respectively. Some differences remained. For example, HIV/AIDS patients not receiving or complying with antiretroviral treatment reported more depression symptoms and were more likely to possess DSM-IV diagnoses of substance dependence or recurrent Major Depressive Disorder. Previous studies of antiretroviral medication adherence failure have reported similar findings [32] [33] [34] . To determine if the present findings regarding sensorimotor differences across groups were confounded with the effects of substance dependence or depression, a secondary analysis was performed. That analysis found no significant effects of the background variables and thereby discounted their role.
The pattern of group differences illustrated in Fig. 1 suggests a deleterious effect of HIV/AIDS on 2 related measures of balance: FBOS and Equilibrium Quotient. The results shown in Fig. 1 also suggest that antiretroviral treatment does not reverse the HIV/AIDS-associated deficits in balance. One must be cautious, however, in accepting the null hypothesis of no treatment effect. The present study examined the effects of antiretroviral treatment in a between-subjects design and may therefore lack power for detecting subtle effects. Future studies should examine the effects of antiretroviral treatment within a repeated measures design where patients are evaluated before and during treatment.
A higher sensory threshold was found among untreated HIV/AIDS patients in comparison to the seronegative control group. The presence of distal sensory neuropathy in HIV/AIDS patients is well-documented [e.g., 35] . It is clinically apparent in approximately 50% of cases not previously exposed to HAART [36] . These data, combined with the present demonstration of a significant correlation between viral load and vibrotactile threshold, suggest that HIV-1 can cause a distal neuropathy.
Treatment with a single NRTI appeared to normalize vibrotactile threshold and eliminate this sign of distal neuropathy in HIV/AIDS patients. Although NRTI treatment has typically been shown to have the opposite effect, it is worth noting that 13 of the 25 patients assigned to the NRTI group were receiving zidovudine. Zidovudine is arguably associated with a lower prevalence and more moderate degree of neuropathy [37] [38] [39] than other NRTIs, especially didanosine and stavudine. Thus, the positive effect of zidovudine in reducing HIV-1associated peripheral neuropathy may have predominated over its own negative effects on peripheral nerve function.
Highly active antiretroviral therapy was associated a significant elevation in vibrotactile threshold. This finding is consistent with other data indicating that the incidence of distal neuropathy increases significantly with the number of drugs comprising the treatment regimen [40] . Patients receiving HAARTwithin the present study were also more likely to be exposed to NRTIs other than zidovudine and could thereby incur greater neurotoxicity.
The present study revealed no relationship between distal neuropathy and balance abnormalities in patients with HIV/AIDS. For example, vibrotactile threshold was influenced by the type of antiretroviral therapy whereas balance was not. In addition, vibrotactile threshold was found to be uncorrelated with the balance measures (all r's < 0.19, all p's > 0.07). The explanation for balance abnormalities among HIV/AIDS in the present study may therefore relate more to central than peripheral nervous system dysfunction. The demonstration that eye closure was essential to demonstrating group differences in balance argues further in favor of an explanation rooted in the CNS. Future studies should directly test the hypothesis by comparing MRI, balance, and gait findings within the same group of patients. It was, unfortunately, not possible to perform MRI scans, or conduct clinical neurological exams, of the 168 participants in the present study because of limited funds.
The balance and vibrotactile threshold abnormalities demonstrated presently should be interpreted in a larger context. Although group differences were found, the abnormalities are, on average, not so severe as to pose a significant risk to mobility, or operator or workplace safety. The distributional properties of FBOS [41] and EQ scores [42] , and vibrotactile threshold [43] 
